PinkDx
The Client
PinkDx, The Gyne Cancer Company™, is a molecular diagnostics company working to transform how gynecologic cancers are detected and diagnosed. The company combines real-world clinical data, whole-transcriptome sequencing, and machine learning to develop more patient-centered approaches to some of the most persistent challenges in women’s cancer diagnostics.
Starting with endometrial cancer, PinkDx is developing a test designed to detect molecular signals associated with the disease from a simple, non-invasive vaginal swab. Its peer-reviewed research has demonstrated the scientific potential of this approach, and the company is now advancing multi-center clinical validation as it works toward bringing its first diagnostic product to market.
As PinkDx moves from scientific discovery toward clinical validation and commercialization, the company is investing in scalable technology infrastructure capable of supporting the rigorous genomic processing, machine learning, traceability, and operational requirements of a production diagnostics environment.
Summary
Molecular Diagnostics Platform
Healthcare & Life Sciences
AWS HealthOmics, AWS Step Functions, Kiro, Terraform, AWS CodePipeline
Solution Architecture, Delivery Management, AI/Data Engineering, DevOps Engineering, Quality Assurance
RevStar partnered with PinkDx to establish a scalable foundation for its genomic processing and machine learning workflows. The solution automates bioinformatics processing, quality-control, and machine learning analysis while creating the traceability and operational foundation needed to support clinical validation and future commercial scale.
Established a production-ready cloud foundation that automates genomic processing, supports growing validation demands, and can evolve alongside PinkDx as the company advances toward commercialization and expands its technology needs.
The Team
